These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2891483)

  • 1. The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.
    Hartman NR; Jardine I
    Drug Metab Dispos; 1987; 15(5):661-4. PubMed ID: 2891483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, purification and structure elucidation of cyclosporin A metabolites in rabbit and man.
    Wallemacq PE; Lhoëst G; Dumont P
    Biomed Environ Mass Spectrom; 1989 Jan; 18(1):48-56. PubMed ID: 2706369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and biotransformation of the cyclosporine metabolite M-17 in the rabbit.
    Copeland K; Lukowski M; Yatscoff R; Thliveris J; Honcharik N
    Drug Metab Dispos; 1990; 18(2):226-30. PubMed ID: 1971578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of cyclosporine and 18 metabolites in blood, bile, and urine by high-performance liquid chromatography.
    Christians U; Schlitt HJ; Bleck JS; Schiebel HM; Kownatzki R; Maurer G; Strohmeyer SS; Schottmann R; Wonigeit K; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):609-13. PubMed ID: 3284110
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-reactivity of cyclosporine metabolites in two different radioimmunoassays in which the same specific monoclonal antibody is used.
    Wallemacq PE; Lee SC; Lhoëst G; Hassoun A
    Clin Chem; 1990 Feb; 36(2):385. PubMed ID: 2302787
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive activity and toxicity of cyclosporine metabolites characterized by mass spectroscopy and nuclear magnetic resonance.
    Copeland KR; Yatscoff RW
    Transplant Proc; 1990 Jun; 22(3):1146-9. PubMed ID: 2349676
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.
    Abecassis M; Wong PY; Mason N; Cheung F; Mee AV; Cole EH; Langer B; Cohen Z; Levy GA
    Can J Surg; 1988 May; 31(3):145-50. PubMed ID: 2966666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of cyclosporine metabolites produced in a hepatic microsomal system.
    Cheung F; Wong PY; Cole E; Cohen Z; Levy GA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):633-6. PubMed ID: 3363659
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of cyclosporine metabolites in human bile, blood, and urine by high-performance liquid chromatography/radioimmunoassay/fast atomic bombardment mass spectroscopy.
    Cheung F; Wong PY; Loo J; Cole EH; Levy GA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):602-8. PubMed ID: 3284109
    [No Abstract]   [Full Text] [Related]  

  • 11. Selection of an optimal assay method for monitoring cyclosporine therapy.
    Rosano TG; Brooks CA; Dybas MT; Cramer SM; Stevens C; Freed BM
    Transplant Proc; 1990 Jun; 22(3):1125-8. PubMed ID: 2349672
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of cyclosporine metabolites in therapeutic monitoring and immunosuppression.
    Rosano TG; Freed BM; Pell MA; Dybas MT; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1699-703. PubMed ID: 2950633
    [No Abstract]   [Full Text] [Related]  

  • 13. Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 2. Cross-reactivity of the antisera with cyclosporine metabolites.
    Lensmeyer GL; Wiebe DA; Carlson IH; deVos DJ
    Clin Chem; 1990 Jan; 36(1):119-23. PubMed ID: 2297901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of activated human lymphocytes to cyclosporine and its metabolites.
    Zeevi A; Venkataramanan R; Burckart G; Wang CP; Murase N; Van Thiel DH; Starzl TE; Makowka L; Duquesnoy RJ
    Hum Immunol; 1988 Feb; 21(2):143-53. PubMed ID: 2966788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic significance of cyclosporine metabolites.
    Ryffel B; Foxwell BM; Mihatsch MJ; Donatsch P; Maurer G
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):575-84. PubMed ID: 3363656
    [No Abstract]   [Full Text] [Related]  

  • 17. Mass spectrometric analysis of cyclosporine metabolites.
    Hartman NR; Jardine I
    Biomed Environ Mass Spectrom; 1986 Jul; 13(7):362-72. PubMed ID: 2943349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of cyclosporins by high-performance liquid chromatography and mass spectrometric study of cyclosporin metabolites.
    Tuominen J; Suortti T; Ishikawa K; Lundell J; Koga Y
    Rapid Commun Mass Spectrom; 1998; 12(16):1085-91. PubMed ID: 9737014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isolation, structural characterization, and immunosuppressive activity of cyclosporin G (NVa2-cyclosporine) metabolites.
    Copeland KR; Yatscoff RW
    Ther Drug Monit; 1991 Jul; 13(4):281-8. PubMed ID: 1780958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.
    Maurer G; Loosli HR; Schreier E; Keller B
    Drug Metab Dispos; 1984; 12(1):120-6. PubMed ID: 6141902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.